U.S. panel backs first-of-a-kind COVID-19 pill from Merck
Wednesday, December 1, 2021
WASHINGTON -- A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.
Subscribe below or log in with your password here.
For more than 115 years, the Southeast Missourian has written the first draft of local history. We have aspired to enrich, entertain, educate and inform. Our core values have remained firm: truth, service, quality, integrity and community. Support our mission.
Join today
Note: Special discounts available to new subscribers only. Print subscriptions may include up to 13 Premium Issues per year, which include special magazines. For each Premium Issue, your account balance will be charged an additional fee in the billing period when the section publishes. This will result in shortening the length of your billing period.